| Serial Number | 97775493 |
| Word Mark | HHH HAS SYNTHESIS |
| Filing Date | Tuesday, January 31, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, October 29, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 3, 2024 |
| Goods and Services | Custom manufacture of pharmaceutical active ingredients for third parties and to the order and specification of others |
| Description of Mark | The mark consists of a red fanciful H design comprised of three capital H letters in special font, interlocking with each other at the center of the bar of each capital letter H. To the right are the words "HAS Synthesis" in grey. "HAS" is all capital letters. The literal element " Synthesis" is with an initial capital letter followed by lower case letters. The color white in the mark is background only and is not claimed as a feature of the mark. |
| Indication of Colors claimed | The color(s) red and grey is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "SYNTHESIS" |
| Goods and Services | Research and development of pharmaceuticals for the treatment of cancer, rare diseases and cancer supportive care; scientific research in the field of chemical technologies; scientific research in the field of pharmaceutical technologies; engineering, including in the field of chemical and pharmaceutical technology; technical scientific research in the field of pharmaceutical studies; quality assessment, namely, product quality evaluation; chemical analysis; research in the field of chemistry; chemistry services, namely, research and development and consultation therefor, in the field of chemistry, to achieve chemical and analytical reproducibility; biological research; product quality testing for quality control purposes; surveying; testing of materials; research in the field of physics; scientific and industrial research in the field the development of medicines and medical active ingredients; advice in the field of chemical research, namely, scientific research consulting in the field of chemistry; industrial research in the field of chemistry; industrial research in the field of pharmaceutical technologies; consulting services in the field of pharmaceutical technology development |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, February 18, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, February 18, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | HAS Healthcare Advanced Synthesis SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Biasca CH-6710 CH |
| Party Name | HAS Healthcare Advanced Synthesis SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Biasca CH-6710 CH |
| Event Date | Event Description |
| Friday, February 3, 2023 | NEW APPLICATION ENTERED |
| Saturday, February 18, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 31, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 27, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, October 31, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 31, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 31, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 31, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 1, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 26, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, April 17, 2024 | FINAL REFUSAL WRITTEN |
| Wednesday, April 17, 2024 | FINAL REFUSAL E-MAILED |
| Wednesday, April 17, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, June 27, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 14, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 3, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 29, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, June 27, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, June 27, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, June 27, 2024 | EXAMINER'S AMENDMENT ENTERED |